← Back to PMCB

PharmaCyte Biotech, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJan 2026Filed 17/03/2026Oct 2025Filed 17/03/2026Jul 2025Filed 17/03/2026Jan 2025Filed 17/03/2026Oct 2024Filed 17/03/2026Jul 2024Filed 17/03/2026Jan 2024Filed 17/03/2025Oct 2023Filed 17/03/2025
$0$0$0$0$0$0$0$0
$0.7−$7.4−$8.4−$3−$1.5$23−$0.6$2.8
−$0.17−$1.24−$1.23−$0.44−$0.39$1.90−$0.65−$0.26
9.36.86.877.67.98.68.8

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.